Baillie Gifford & CO Twist Bioscience Corp Transaction History

Baillie Gifford & CO

$127 Billion
Q4 2024

A detailed history of Baillie Gifford & CO transactions in Twist Bioscience Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 777,537 shares of TWST stock, worth $32.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

777,537

Previous 834,339 6.81%

Holding current value

$32.1 Million

Previous $37.7 Million 4.15%

% of portfolio

0.03%

Previous 0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$36.89 - $52.7 $2.1 Million - $2.99 Million	-56,802 Reduced 6.81%	777,537 $36.1 Million
Q3 2024 Nov 05, 2024	SELL	$36.72 - $58.88 $5.51 Million - $8.83 Million	-149,963 Reduced 15.24%	834,339 $37.7 Million
Q2 2024 Jul 25, 2024	SELL	$27.95 - $53.0 $6.8 Million - $12.9 Million	-243,226 Reduced 19.81%	984,302 $48.5 Million
Q1 2024 May 01, 2024	BUY	$32.28 - $41.5 $4.29 Million - $5.51 Million	132,770 Added 12.13%	1,227,528 $42.1 Million
Q4 2023 Jan 26, 2024	SELL	$15.08 - $38.61 $2.62 Million - $6.7 Million	-173,537 Reduced 13.68%	1,094,758 $40.4 Million
Q3 2023 Nov 13, 2023	SELL	$18.62 - $26.57 $30,369 - $43,335	-1,631 Reduced 0.13%	1,268,295 $25.7 Million
Q2 2023 Jul 28, 2023	BUY	$11.49 - $20.46 $2.18 Million - $3.89 Million	189,896 Added 17.58%	1,269,926 $26 Million
Q1 2023 May 03, 2023	SELL	$14.6 - $30.9 $81,015 - $171,464	-5,549 Reduced 0.51%	1,080,030 $16.3 Million
Q4 2022 Jan 24, 2023	BUY	$21.92 - $39.37 $4.27 Million - $7.66 Million	194,611 Added 21.84%	1,085,579 $25.8 Million
Q3 2022 Oct 27, 2022	BUY	$33.44 - $56.56 $29.8 Million - $50.4 Million	890,968 New	890,968 $31.4 Million

Others Institutions Holding TWST

# of Institutions

270

Shares Held

67.2M

Call Options Held

118K

Put Options Held

40.2K

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.33B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Twist Bioscience Corp Transaction History